Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0. It has been cited 197 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P01CA214278,P01CA066726,R01CA120409
U.S. Department of Veterans Affairs
Grant: IK2BX004183
NCI NIH HHS
Grant: P01 CA066726
NCI NIH HHS
Grant: P01 CA214278
NCI NIH HHS
Grant: R01 CA120409
National Institutes of Health
Grant: 3P01CA214278-02S1
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
National Institutes of Health
Grant: 1R01CA120409-01
Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells
National Institutes of Health
Grant: 5P01CA066726-07
MESOTHELIOMA CLINICAL TRIALS
National Institutes of Health
Grant: 5IK2BX004183-04
Engineered T Cells Targeting Abnormal Glycans in Metastatic Prostate Cancer
FWCI
9.20
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords